Evidence map›Paper›PMID 39774513›Full record

Trial reportPloS one2025

Effects of different educational interventions on cervical cancer knowledge and human papillomavirus vaccination uptake among young women in Japan: Preliminary results of a cluster randomized controlled trial.

Yuko Takahashi, Yukifumi Sasamori, Risa Higuchi, Asumi Kaku, Tomoo Kumagai, Saya Watanabe, Miki Nishizawa, Kazuki Takasaki, Haruka Nishida, Takayuki Ichinose and 6 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yuko TakahashiDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Yukifumi SasamoriDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Risa HiguchiDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Asumi KakuDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Tomoo KumagaiDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Saya WatanabeDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Miki NishizawaDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Kazuki TakasakiDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Haruka NishidaDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Takayuki IchinoseDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Mana HiranoDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Yuko MiyagawaDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Haruko HiraikeDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Koichiro KidoDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Hirono IshikawaGraduate School of Public Health, Teikyo University, Tokyo, Japan.
Kazunori NagasakaDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.ORCID 0000-0002-0696-5175

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence and mortality rates of cervical cancer are increasing among young Japanese women. In November 2021, the Japanese Ministry of Health, Labour, and Welfare reinstated the active recommendation of the human papillomavirus (HPV) vaccine, after it had been suspended in June 2013 due to reports of adverse reactions. However, vaccine hesitancy is prevalent in the younger generation in Japan. To identify obstacles to vaccine uptake, we conducted a randomized study using different methods to provide educational content to improve health literacy regarding cervical cancer and HPV vaccination among Japanese female students. We surveyed 188 Japanese female students, divided into three groups according to the intervention: no intervention, print-based intervention, and social networking service-based intervention. Twenty questionnaires and the Communicative and Critical Health Literacy scales were used as health literacy scales. Participants' knowledge and health literacy improved regardless of the method of education. In fact, participants acquired proper knowledge when given the opportunity to learn about the importance of the disease and its prevention. Therefore, medical professionals in Japan must provide accurate scientific knowledge regarding routine HPV vaccination and the risk of cervical cancer in young women to improve their health literacy and subsequently increase HPV vaccination rates in Japan, which may lead to cervical cancer elimination. Trial registration number: UMIN000036636.

Indexed as

Health Knowledge, Attitudes, PracticeHealth LiteracyPapillomavirus InfectionsPapillomavirus VaccinesUterine Cervical NeoplasmsVaccinationAdolescentAdultFemaleHealth EducationHuman Papillomavirus VirusesHumansJapanSurveys and QuestionnairesYoung AdultPapillomavirus Vaccines

Identifiers

PMID39774513
PMCPMC11706404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.